hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 00:58:32 - browse：517

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Readout LOUD podcast: How biotech is using artificial intelligence

WSS

Doctors' information doesn't help them choose wisely when sick

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

The Harvard botanist who searched for psychedelics in the Amazon

Alabama IVF ruling threatens families facing fatal genetic disease

In utero gene editing: an explainer

A new nitrogen execution bill also undermines medical licensing

focus

hotspot

leisure time

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

To avoid data mishandling cases, universities eye AI and other tools

Hepatitis C has a cure — but many Americans still lack access to it

'Revelatory' study finds a smoking impact that remains after quitting

What does generative AI mean for health care? We asked experts

What we’ve learned from the Aduhelm mess

Cancer drug shortages should be causing more outrage

Key House Republican on health care plans exit from Congress

Jerome Adams on the need for new antivirals for Covid

STAT readers on older presidents, polypills, Medicare, and more

focus

Antivenom research: Lessons from HIV applied in search for universal antidote

The Readout: Gilead, Bernie Sanders, and other pharma news

Dario to buy mental health app maker Twill in cash and stock deal

Antivenom research: Lessons from HIV applied in search for universal antidote

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

leisure time

hotspot

focus

leisure time